Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.099
-0.086 (-3.93%)
Jan 22, 2025, 12:10 PM EST - Market open
Minerva Neurosciences Employees
Minerva Neurosciences had 9 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$367,950
Market Cap
14.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
NERV News
- 2 months ago - Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 9 months ago - Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 11 months ago - US FDA declines to approve Minerva Neurosciences' schizophrenia drug - Reuters
- 11 months ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences: There's Probably Time For One More Rally - Seeking Alpha
- 1 year ago - Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market - GlobeNewsWire